about
A multiparametric magnetic resonance imaging-based risk model to determine the risk of significant prostate cancer prior to biopsy.Diagnostic accuracy of 68 Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition ofProtocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic
P50
description
researcher (ORCID 0000-0002-5531-6104)
@en
wetenschapper
@nl
name
Pim J van Leeuwen
@en
Pim J van Leeuwen
@nl
type
label
Pim J van Leeuwen
@en
Pim J van Leeuwen
@nl
prefLabel
Pim J van Leeuwen
@en
Pim J van Leeuwen
@nl
P31
P496
0000-0002-5531-6104